Abstracts tagged "rheumatoid arthritis (RA) and epidemiologic methods"

Abstract Number: 171 • 2019 ACR/ARP Annual Meeting
Performance of 2010 ACR/EULAR and 1987 ACR Criteria for Classification of Rheumatoid Arthritis in a Population-based Incidence Cohort, 2010-2014
Elena Myasoedova¹, John Davis ¹, Eric Matteson ² and Cynthia Crowson ³, ¹Mayo Clinic, Rochester, MN, ²Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA, Rochester, ³Mayo Clinic Rochester, Rochester
Background/Purpose: Previous studies evaluated performance of the 2010 American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) criteria for classification of rheumatoid arthritis (RA) in…
Abstract Number: 172 • 2019 ACR/ARP Annual Meeting
Is the Epidemiology of Rheumatoid Arthritis (RA) Changing? Results from a Population-based Incidence Cohort of RA Patients, 2005-2014
Elena Myasoedova¹, John Davis ¹, Eric Matteson ² and Cynthia Crowson ³, ¹Mayo Clinic, Rochester, MN, ²Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA, Rochester, ³Mayo Clinic Rochester, Rochester
Background/Purpose: The incidence and prevalence of rheumatoid arthritis (RA) vary substantially between populations in different geographic areas and over time. Recent trends in RA incidence…
Abstract Number: 201 • 2019 ACR/ARP Annual Meeting
Identification of Patients with Rheumatoid Arthritis Treated with Biologics Using Standardized Vocabularies
Runsheng Wang¹, Thomas Falconer ² and George Hripcsak ², ¹Columbia University Medical Center, Division of Rheumatology, New York City, ²Columbia University Medical Center, Department of Biomedical Informatics, New York City
Background/Purpose: To improve efficiency and transportability of observational research, common data models have been developed and maintained to translate data from source vocabularies into standardized…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].